Nausea
Conditions
Interventions
First stage - 1st measurement: evaluation using the QLQ-C30 instrument to establish a baseline quality of life and symptoms presented by the clients + face-to-face intervention about the side effects
Other
Sponsors
Universidade Federal do Ceará
Ambulatório de Quimioterapia do Hospital Universitário Walter Cantídio
Eligibility
Inclusion criteria
Inclusion criteria: Patients with diagnose of solid cancers of gastrointestinal tract, breast and lungs, because these represent the majority of people assisted in the referred outpatient care; Patients who are in the first or second chemotherapy cycle; Patients whose age is superior to 18 years old; Patients who scored 15 in Glasgow Coma Scale.
Exclusion criteria
Exclusion criteria: Patients who reached scores inferior to 60%.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparing to the control group, participants in the experimental group who will receive telenursing to manage the side effects of chemotherapy will report better quality of life and lower scores of symptoms. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparing to the control group, participants in the experimental group who will receive telenursing to manage the side effects of chemotherapy will report better quality of life and lower scores of symptoms, such as nausea, vomiting, inappetence, constipation, diarrhea, peripheral neuropathy , anxiety, sleep problems and myelosuppression (risk of infection and risk of bleeding). | — |
Countries
Brazil
Contacts
Public ContactAndrea Rodrigues
Universidade Federal do Ceará
Outcome results
None listed